OUTLOOK THERAPEUTICS, INC. (OTLK) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $6.81M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $6.81M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $6.81M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 36.58M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 6.81M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Deferred Revenue, Current · Deferred Revenue, Noncurrent |
| Deferred revenue due within one year | (m) | Deferred Revenue, Current |
| Deferred revenue due after one year | (m) | Deferred Revenue, Noncurrent · Deferred Revenue, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | (m) | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Deferred Revenue, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Income taxes payable | $302.00K |
| Operating lease obligations | $204.14K |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $6.81M | (m) | (m) | (m) | $36.58M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $13.64M | (m) | (m) | (m) | $50.89M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $7.32M | (m) | (m) | (m) | $56.79M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $10.19M | (m) | (m) | (m) | $50.77M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $10.26M | (m) | (m) | (m) | $59.58M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $7.77M | (m) | (m) | (m) | $51.54M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $12.19M | (m) | (m) | (m) | $67.30M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $7.97M | (m) | (m) | (m) | $101.90M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $5.55M | (m) | (m) | (m) | $130.77M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $4.36M | (m) | (m) | (m) | $193.26M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $3.48M | (m) | (m) | (m) | $46.03M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $6.57M | (m) | (m) | (m) | $46.74M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $5.06M | (m) | (m) | (m) | $49.95M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.62M | (m) | (m) | (m) | $43.54M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $4.17M | (m) | (m) | (m) | $46.93M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $3.49M | (m) | (m) | (m) | $19.79M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $2.48M | (m) | (m) | (m) | $18.51M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $4.16M | (m) | (m) | (m) | $31.72M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.55M | (m) | (m) | (m) | $29.85M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.20M | (m) | (m) | (m) | $18.20M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $2.67M | (m) | (m) | (m) | $20.13M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $6.33M | (m) | (m) | (m) | $24.46M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $3.33M | (m) | (m) | (m) | $22.99M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $2.39M | (m) | (m) | (m) | $16.91M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $5.01M | (m) | (m) | (m) | $19.28M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $3.31M | (m) | (m) | (m) | $33.69M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $2.57M | (m) | (m) | (m) | $35.83M | (m) | (m) | (m) | $3.92M | (m) |
| 2019-09-30 | (m) | $2.28M | (m) | (m) | (m) | $27.90M | (m) | (m) | (m) | $3.94M | (m) |
| 2019-06-30 | (m) | $2.99M | $5.87M | (m) | $3.98M | $34.57M | (m) | $2.34M | $3.53M | $3.98M | $0.00 |
| 2019-03-31 | (m) | $5.11M | $6.45M | (m) | $3.29M | $40.22M | (m) | $2.34M | $4.12M | $3.29M | $0.00 |
| 2018-12-31 | (m) | $4.70M | $7.09M | (m) | $3.40M | $40.18M | (m) | $2.39M | $4.70M | $3.40M | $0.00 |
| 2018-09-30 | (m) | $3.61M | $4.50M | (m) | $3.51M | $43.09M | (m) | $1.74M | $2.76M | $3.51M | $0.00 |
| 2018-06-30 | (m) | $3.35M | $5.27M | (m) | $2.36M | $43.35M | (m) | $2.21M | $3.06M | $2.36M | $0.00 |
| 2018-03-31 | (m) | $3.61M | $6.01M | (m) | $2.35M | $43.06M | (m) | $2.68M | $3.33M | $2.35M | $0.00 |
| 2017-12-31 | (m) | $3.63M | $6.78M | (m) | $2.56M | $40.17M | (m) | $2.75M | $4.03M | $2.56M | $0.00 |
| 2017-09-30 | (m) | $10.95M | $7.55M | (m) | $2.57M | $51.46M | (m) | $3.09M | $4.47M | $2.57M | $0.00 |
| 2017-06-30 | (m) | $11.79M | $5.46M | (m) | $899.91K | $46.07M | (m) | $1.21M | $4.24M | $899.91K | $0.00 |
| 2017-03-31 | (m) | $12.15M | $5.76M | (m) | $912.47K | $44.31M | (m) | $1.21M | $4.55M | $912.47K | $0.00 |
| 2016-12-31 | (m) | $11.05M | $6.06M | (m) | $865.53K | $42.28M | (m) | $1.21M | $4.85M | $865.53K | $0.00 |
| 2016-09-30 | (m) | $5.07M | $6.37M | (m) | $761.33K | $28.91M | (m) | $1.21M | $5.15M | $761.33K | $0.00 |
| 2016-06-30 | (m) | $4.53M | $6.86M | (m) | $676.23K | $31.43M | (m) | $1.98M | $4.88M | $676.23K | $0.00 |
| 2016-03-31 | (m) | $14.42M | $7.36M | (m) | $591.13K | $45.30M | (m) | $1.98M | $5.38M | $591.13K | $0.00 |
| 2015-09-30 | (m) | $11.56M | $8.35M | (m) | $284.71K | $62.56M | (m) | $1.98M | $6.37M | $284.71K | $0.00 |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |